Funded Tech Companies
BioLamina
Wondering who provided funding to BioLamina? Lauxera Capital Partners, Northislet and Bure joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
BioLamina
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
BioLamina AB Löfströms Allé 5
Sundbyberg, 172 66
SE
Sundbyberg, 172 66
SE
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
BioLamina is a biotechnology company built on a scientific foundation with a legacy in matrix biology and cell culture-based research. We want to help scientists who have struggled for decades to culture embryonic stem cells, induced pluripotent stem cells, and other primary cells. By providing tools for efficient and easy culture, BioLamina aims to smooth the path towards safe and effective cell therapy. Whether your goal is to answer basic scientific questions, advance cell therapies, or make models for drug development, our products can help you in your journey. The power of our Biolaminin® substrates has been shown in numerous publications and they will continue to provide vital support for the stem cell community -- from scientific concepts to clinical studies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/12/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Veronica Sköld
Chief Financial Officer
Magnus Åkerhielm
Chief Operating Officer
Ulrika Ljungkvist
Chief Scientific Officer
Therése Kallur
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs